CREATSENS HEALTH
The Renalyse’s platform is an innovative and patented point-of-care technology that monitors the main indicators of kidney function quickly from home.
The technology is a low-cost sensor that combines nanotechnology and direct printing procedures to provide real-time information to the doctor. That means a drastic reduction of cost and the possibility to use recyclable material.
The patient deposits the drop of blood on the sensor, which is then inserted in an easy-to-use device, cloud-connected, where a patient’s biological information can be shared in real-time with the doctor. Real time information allows the doctor to better adjust medication doses, prevent arrhythmias and predict acute episodes before they happen.
Through personalization, we will address cost, waiting time and treatment quality issues. This is important with the recent pandemics, where the patients can be monitored from home.